Leuven Lung Cancer Group | Home

June 2023 Selected Trial: HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy.
June 2023 Selected Trial: CARMEN-LC06: Open label, Phase 2 study, evaluating the efficacy and safety of tusamitamab ravtansine (ADC) in participants with CEACAM5 negative-moderate expression and high circulating CEA non-squamous non-small-cell lung cancer
June 2023 New Article: Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

Welkom op de website van de Leuven Lung Cancer Group

LLCG is een samenwerkingsverband tussen het Zorgprogramma Respiratoire Oncologie van het UZ Leuven en verwijzende artsen.

Ik ben patient

Welcome to the website of the Leuven Lung Cancer Group

LLCG is a cooperation between the Clinical Program Respiratory Oncology of the University Hospital Leuven and referring specialists.

I am a health care professional